GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » Cyclically Adjusted PS Ratio

Syneos Health (FRA:8IN) Cyclically Adjusted PS Ratio : 1.04 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syneos Health Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Syneos Health's current share price is €40.00. Syneos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 was €38.48. Syneos Health's Cyclically Adjusted PS Ratio for today is 1.04.

The historical rank and industry rank for Syneos Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:8IN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.82   Med: 0.99   Max: 1.38
Current: 1.04

During the past years, Syneos Health's highest Cyclically Adjusted PS Ratio was 1.38. The lowest was 0.82. And the median was 0.99.

FRA:8IN's Cyclically Adjusted PS Ratio is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.21 vs FRA:8IN: 1.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Syneos Health's adjusted revenue per share data for the three months ended in Jun. 2023 was €12.084. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €38.48 for the trailing ten years ended in Jun. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Syneos Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Syneos Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Cyclically Adjusted PS Ratio Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.92

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.33 0.92 0.87 1.00

Competitive Comparison of Syneos Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Syneos Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Syneos Health's Cyclically Adjusted PS Ratio falls into.



Syneos Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Syneos Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=40.00/38.48
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syneos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Syneos Health's adjusted Revenue per Share data for the three months ended in Jun. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=12.084/128.7287*128.7287
=12.084

Current CPI (Jun. 2023) = 128.7287.

Syneos Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 3.684 98.790 4.800
201312 3.531 98.326 4.623
201403 3.717 99.695 4.800
201406 4.030 100.560 5.159
201409 4.413 100.428 5.657
201412 4.621 99.070 6.004
201503 4.523 99.621 5.845
201506 4.970 100.684 6.354
201509 5.309 100.392 6.808
201512 6.365 99.792 8.211
201603 6.641 100.470 8.509
201606 6.343 101.688 8.030
201609 6.282 101.861 7.939
201612 7.008 101.863 8.856
201703 6.478 102.862 8.107
201706 6.294 103.349 7.840
201709 7.916 104.136 9.785
201712 8.718 104.011 10.790
201803 8.209 105.290 10.036
201806 8.827 106.317 10.688
201809 9.275 106.507 11.210
201812 9.285 105.998 11.276
201903 9.581 107.251 11.500
201906 9.852 108.070 11.735
201909 10.176 108.329 12.092
201912 10.360 108.420 12.301
202003 9.966 108.902 11.780
202006 8.553 108.767 10.123
202009 8.837 109.815 10.359
202012 8.890 109.897 10.413
202103 9.628 111.754 11.090
202106 10.137 114.631 11.384
202109 10.937 115.734 12.165
202112 11.576 117.630 12.668
202203 11.621 121.301 12.333
202206 12.489 125.017 12.860
202209 13.077 125.227 13.443
202212 12.437 125.222 12.785
202303 12.265 127.348 12.398
202306 12.084 128.729 12.084

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Syneos Health  (FRA:8IN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Syneos Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Syneos Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (FRA:8IN) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines